Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Short Report
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,199 | Dovepress* | 4,836+ | 1,045 | 5,881 | |
| PubMed Central* | 363 | 106 | 469 | ||
| Totals | 5,199 | 1,151 | 6,350 | ||
|
*Since 17 March 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 4 | 4 |
View citations on PubMed Central and Google Scholar